Login to Your Account



NewCo News

Oligomerix Targets Tau Protein To Tackle Alzheimer's Disease

By Catherine Shaffer
Staff Writer

Wednesday, February 8, 2012

New York-based biotech start-up Oligomerix Inc. is pressing a multipronged attack against tau protein, an alternate Alzheimer's disease target, using a combination of small-molecule and antibody therapeutics coupled with biomarker strategies.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription